Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Up; Powell To Make Jackson Hole Debut

Fri, 24th Aug 2018 11:54

LONDON (Alliance News) - Stocks in London were marginally higher at midday on Friday ahead of a highly anticipated speech from the head of the US Federal Reserve.With US-China trade talks demoting a lack of significant progress, investors will now shift focus to a speech by Federal Reserve Chairman Jerome Powell in the afternoon for fresh updates on the outlook for the US economy. Investors also adopted a cautious stance ahead of the long bank holiday weekend in the UK.The FTSE 100 index was up 0.1%, or 10.10 points at 7,573.32. The FTSE 250 was up 0.2%, or 31.14 points, at 20,696.00, and the AIM All-Share was down 0.3%, or 3.69 points, at 1,088.86.The Cboe UK 100 was up 0.1% at 12,831.08, the Cboe UK 250 was up 0.1% at 18,783.21, and the Cboe UK Small Companies was up 0.1% at 12,342.86.On the London Stock Exchange, Antofagasta was the best blue chip performer, up 3.2% after RBC Capital upgraded the Chilean copper miner to Outperform from Sector Perform. Shire was up 2.2% after the US Food & Drug Administration has approved the Irish pharmaceutical company's Takhzyro drug to treat a rare genetic disease. The disease, hereditary angioedema, causes attacks of swelling in different parts of the body and can be life-threatening. Approval from the FDA follows a phase III study of 125 patients in which Takhzyro reduced monthly attacks by, on average, 87% in patients when compared with a placebo.Miners were also higher with Anglo American, up 1.6%, Rio Tinto, up 1.1%, BHP Billiton, up 1.1%. "A rebound in copper, platinum and palladium has helped mining stocks. The cooling of the Chinese economy has triggered major volatility in the metals market, as investors are worried about future demand. For the time being, the size of the tariffs being imposed on Chinese goods imported into the US are relatively small, but if it is drawn out, it could chip away at growth," said David Madden, market analyst at CMC Markets.Conversely, housebuilders were weighing on the large cap index amid a decline in UK mortgage approval figures in July.Berkeley Group was down 1.8%, Barratt Developments, down 1.6%, Persimmon, down 1.1%, Taylor Wimpey, down 1.0%.The number of mortgages approved in July fell to 39,584 from 40,330 in June. Economists had forecast approvals to rise to 40,650, data from UK Finance showed. "Housebuilders have taken a knock as a double whammy of lower new approved mortgages and a five-month low in mortgage lending weighed on the sector," IG Group analyst Chris Beauchamp said. Additionally, midcap peers McCarthy & Stone, Bovis Homes and Bellway were down 1.6%, 1.4% and 0.9%, respectively. Sterling was quoted at USD1.2823 at midday, compared to USD1.2830 at the London equities close on Thursday. The pound was flat with investors unmoved by new details covering a "no deal" Brexit unveiled by Brexit Secretary Dominic Raab on Thursday. In mainland Europe, the CAC 40 in Paris was up 0.5% while the DAX 30 in Frankfurt was up 0.2%.The euro was flat against the dollar quoted at USD1.1565 at midday, from USD1.1569 at the European equities close Thursday, following solid Germany GDP data. Germany's economy expanded at a faster pace as initially estimated on domestic demand in the second quarter, detailed data from Destatis showed.The largest euro area economy grew 0.5% sequentially, following the 0.4% increase in the first quarter. The rate came in line with the estimate released on August 14.On a yearly basis, gross domestic product advanced at a faster pace of 2.3% after expanding 1.4% a quarter ago. Meanwhile, the calendar-adjusted GDP growth slowed slightly to 2% from 2.1%. Both annual rates matched expectations.Stocks in New York were set for a higher open as Fed Chair Powell gets set to take the stage at the Economic Policy Symposium in Jackson Hole.The DJIA, the S&P 500 index and the Nasdaq Composite were all called up 0.2%.Powell will make his maiden address to some of the world's most prominent central bankers at the gathering in Wyoming at 1500 BST, a week after US President Donald Trump took aim at the Fed chair.Earlier this week, the Fed has pencilled in two more interest rate hikes this year despite risks from trade conflicts and emerging market turmoil.In response, Trump reiterated his criticism of the Fed's monetary policy, saying he was "not thrilled" with the central bank for raising interest rates and that it should do more to help boost the US economy. It remains to be seen whether Powell will respond to Trump's criticism.Powell was hand picked by Trump to lead the US central bank.
More News
30 Nov 2018 07:38

LONDON MARKET PRE-OPEN: Ecolab To Acquire Bioquell For GBP141 Million

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday as investors await a meeting of US and Chinese leaders at the G20 summit.IG futures indicate the FTSE is

Read more
30 Nov 2018 07:23

Shire gets EC approval for hereditary angioedema jab

(Sharecast News) - Shire's injectable treatment for hereditary angioedema (HAE) has been cleared for launch in European, having enjoyed early success in the US.

Read more
28 Nov 2018 07:53

Shire's Lanadelumab Help Study Meets Primary And Secondary Endpoints

LONDON (Alliance News) - Shire PLC said Tuesday it has published the full results of its phase III Help study of its hereditary angioedema drug Lanadelumab showing that the study met all of its is

Read more
20 Nov 2018 14:34

EU clears Takeda's Shire acquisition on divestment condition

(Sharecast News) - The European Commission has cleared Takeda Pharmaceutical's £46bn acquisition of Shire, subject to the divestment of a bowel disease drug under development by Shire.

Read more
1 Nov 2018 12:48

TOP NEWS: Shire Revenue Climbs On Strong Performance From Immunology

LONDON (Alliance News) - Shire PLC on Thursday updated its guidance and said its revenue grew in the third quarter of of 2018 as a result of strong Immunology division growth, recent product and a

Read more
1 Nov 2018 12:09

Shire sales remain solid, Takeda deal 'on track'

(Sharecast News) - Shire Pharmaceuticals, the subject of a $62bn takeover by Japan's Takeda, said its focus on rare diseases had offset foreign exchange weakness and boosted third-quarter profits.

Read more
1 Nov 2018 08:48

LONDON MARKET OPEN: Oil Stocks And Strong Pound Weigh On FTSE 100

LONDON (Alliance News) - Stocks in London opened mixed on Thursday, with heavyweight oil majors and a stronger pound hampering the FTSE 100, ahead of the Bank of England's interest rate decion

Read more
31 Oct 2018 06:11

Takeda's raises full-year outlook after Q2 profit rise

TOKYO, Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen. That compares with an earlier company estimate of yen an

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 07:35

LONDON MARKET PRE-OPEN: Better-Than-Expected HSBC To Lift FTSE 100

LONDON (Alliance News) - Stocks in London are set to open on firmer ground on Monday, following last week's sell-off, while traders eye Chancellor Philip Hammond's UK government shares in in

Read more
26 Oct 2018 07:52

Takeda Secures JPY1 Trillion Of Financing To Help Shire Deal

LONDON (Alliance News) - Japan's Takeda Pharmaceuticals Inc on Friday said it has secured new financing to help it with its acquisition of FTSE 100 member Shire PLC.The new short-term a

Read more
25 Oct 2018 16:21

Shire hopes to get green light for US Flexbumin manufacture

(Sharecast News) - Shire on Thursday filed a submission to the US food and drug administration to gain approval to manufacture Flexbumin at its new facility in the state of Georgia.

Read more
25 Oct 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 26 October GlencoreQ3 ProductionInternational Consolidated Airlines GroupQ3 Bank 1

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.